share_log

IDEX Biometrics ASA (OTCMKTS:IDXAF) Short Interest Update

Defense World ·  May 3, 2023 03:32

IDEX Biometrics ASA (OTCMKTS:IDXAF – Get Rating) was the recipient of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 3,798,500 shares, a drop of 6.5% from the March 31st total of 4,063,500 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

IDEX Biometrics ASA Price Performance

Shares of OTCMKTS IDXAF opened at $0.17 on Wednesday. The company has a market cap of $192.56 million, a P/E ratio of -5.50 and a beta of 0.96. The company has a quick ratio of 3.85, a current ratio of 4.74 and a debt-to-equity ratio of 0.05. The business has a 50-day simple moving average of $0.09 and a two-hundred day simple moving average of $0.08. IDEX Biometrics ASA has a 52 week low of $0.17 and a 52 week high of $0.17.

Get IDEX Biometrics ASA alerts:

IDEX Biometrics ASA Company Profile

(Get Rating)

IDEX Biometrics ASA is engaged in the development and provision of fingerprint imaging and recognition technology. It offers off-chip fingerprint sensors and on-card enrollment solutions. The company was founded on July 24, 1996 and is headquartered in Fornebu, Norway.

Recommended Stories

  • Get a free copy of the StockNews.com research report on IDEX Biometrics ASA (IDXAF)
  • Do Bank Stocks Go Up When Interest Rates Rise?
  • How to Invest in Vertical Farming Stocks
  • Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding
  • Ecolab: Slow And Steady Wins The Race
  • MGM's Hot Hand Is All In For A Rally, After This Small Break

Receive News & Ratings for IDEX Biometrics ASA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX Biometrics ASA and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment